Alogliptin Benzoate; Pioglitazone Hydrochloride Patent Expiration
Alogliptin Benzoate; Pioglitazone Hydrochloride is Used for treating diabetes and related metabolic disorders, including glycemic and lipid metabolism abnormalities. It was first introduced by Takeda Pharmaceuticals Usa Inc
Alogliptin Benzoate; Pioglitazone Hydrochloride Patents
Given below is the list of patents protecting Alogliptin Benzoate; Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Oseni | US8637079 | Solid preparation comprising alogliptin and pioglitazone | Jun 04, 2029 | Takeda Pharms Usa |
| Oseni | US7807689 | Dipeptidyl peptidase inhibitors | Jun 27, 2028 | Takeda Pharms Usa |
| Oseni | US8173663 | Dipeptidyl peptidase inhibitors |
Mar 15, 2025
(Expired) | Takeda Pharms Usa |
| Oseni | US8288539 | Dipeptidyl peptidase inhibitors |
Mar 15, 2025
(Expired) | Takeda Pharms Usa |
| Oseni | US6890898 | Method of regulating glucose metabolism, and reagents related thereto |
Feb 02, 2019
(Expired) | Takeda Pharms Usa |
| Oseni | US7078381 | Method of regulating glucose metabolism, and reagents related thereto |
Feb 02, 2019
(Expired) | Takeda Pharms Usa |
| Oseni | US7459428 | Method of regulating glucose metabolism, and reagents related thereto |
Feb 02, 2019
(Expired) | Takeda Pharms Usa |
| Oseni | US6303661 | Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals |
Apr 24, 2017
(Expired) | Takeda Pharms Usa |
| Oseni | US6303640 | Pharmaceutical composition |
Aug 09, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US5965584 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US6150383 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US6150384 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US6166042 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US6166043 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US6172090 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US6211205 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US6271243 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Oseni | US6329404 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Alogliptin Benzoate; Pioglitazone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List